The World Health Organization (WHO) today published Edition #140 of its Weekly epidemiological update on the COVID-19 pandemic. As of April 27, 2023, the WHO confirmed nearly 2.8 million new COVID-19 cases, and over 16,000 related... READ →
Coronavirus Today/ May 28th, 2023
Eliminating fake vaccine news with pharmacist, nurse, and physician review.
Apr 27 • 2:15 pm CDT
Apr 27 • 10:44 am CDT
Merck today announced financial results for the first quarter of 2023. In addition, Merck stated it realized lower sales of the oral COVID-19 antiviral Lagevrio™ (Molnupiravir), which decreased 88% to $392 million. This decrease was primarily... READ →
Apr 25 • 2:21 pm CDT
The BMJ today published a study based on U.S. VA data that concluded among people at high risk of progression to severe COVID-19-19, molnupiravir ( Lagevrio™ ) use within five days of SARS-CoV-2 virus infection may... READ →
Apr 25 • 11:21 am CDT
Invivyd, Inc. today announced that the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for VYD222, a monoclonal antibody (mAb) candidate. Invivyd is developing VYD222 to prevent COVID-19 in vulnerable... READ →
Apr 25 • 10:51 am CDT
Atea Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration granted Fast Track designation to bemnifosbuvir for treating COVID-19. Bemnifosbuvir (AT-527) is an oral, direct-acting antiviral drug candidate, a nucleotide polymerase inhibitor that targets... READ →
For more articles, try our search.